ECDC study shows that communication around the benefit and risk balance of vaccination requires a mix of different communication approaches to ensure impact across multiple audiences.
Increase in pertussis cases in EU/EEA: infants under six months of age at the highest risk
During 2023 and until April 2024, EU/EEA countries have reported nearly 60 000 cases of pertussis, a more than 10-fold increase compared to 2022 and 2021.
This report presents the results of a study that dealt specifically with effective communication around the benefit and risk balance of vaccination people’s risk perceptions around vaccines and diseases, and approaches to enhancing communication about the safety and effectiveness of vaccines.
In 2022, 27 European Union/European Economic Area (EU/EEA) countries reported 731 echinococcosis cases. Of these, 299 (41%) cases were reported as Echinococcus granulosus sensu lato, 185 (25%) as E. multilocularis and 247 (34%) as an unknown species.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.